Nusano to Present at William Blair Virtual Radiopharmaceuticals Event

VALENCIA, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CEO Chris Lowe will present at William Blair’s Innovators Series: Radiopharmaceuticals virtual event on Thursday, November 14, 2024. The fireside chat-style presentation will highlight Nusano’s 2025 commercialization plans and provide an overview of how the company will leverage its proprietary technologies to make new supplies of rare and hard-to-produce radioisotopes available for medical and commercial markets.

To listen to the webcast, please contact your representative at William Blair and request a link.

About Nusano
Nusano is a privately held physics company committed to bringing supply stability and innovation to the rapidly emerging and critically undersupplied medical radioisotopes market, and to serving industrial and commercial markets dependent on reliable access to high quality radioisotopes for their products and services. Driven by the company’s proprietary ion source, the Nusano production platform will generate radioisotopes in volumes and varieties exceeding other production methods. Nusano’s breakthrough technologies are poised to help supply the fight against cancer and enable innovation across multiple industries. For more, please visit nusano.com.

Contacts:

• Media: Scott Larrivee, Nusano, 608-345-6629, [email protected]
• Investor Relations: Joyce Allaire, LifeSci Advisors, LLC, 212-915-2569, [email protected]

You May Also Be Interested In

• Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
• Memecoin Launches Today: How MemeToro Uses AI Agents to Build Fair Launch Ecosystems
• TTW Announces the Top 50 Travel Solution Cards in the World for 2026